3Smulders K, van der Hoeven H, Weers-Pothoff I, et al. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation [J]. Chest, 2002, 121 (3):858-862.
4Jones DS, McMeel S, Adair CG, et al. Characterisation and evaluation of novel surfactant bacterial anti-adherent coatings for endotracheal tubes designed for the prevention of ventilator-associated pneumonia [J]. J Pharm Pharmacol, 2003, 55(1):43-52.
5Jones DS, McGovern JG, Woolfson AD, et al. Physicochemical characterization of hexetidine-impregnated endotracheal tube poly(vinyl chloride) and resistance to adherence of respiratory bacterial pathogens [J]. Pharm Res, 2002, 19(6):818-824.
6Lien TC, Lin MY, Chu CC, et al. Ventilator-associated pneumonia with circuit changes every 2 days versus every week [J]. Zhonghua Yi Xue Za Zhi (Taipei), 2001, 64(3):161-167.
7Hess D. Infection control in the intensive care unit. The role of the ventilator circuit [J]. Minerva Anestesiol, 2002, 68(5):356-359.
8Girou E, Loyeau S, Legrand P, et al. Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomised clinical trial [J]. BMJ, 2002, 325(7360):362.
9Bergmans DC, Bonten MJ, Gaillard CA, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placcbo-controlld study [J]. Am J Respir Crit Care Med, 2001, 164(3):382-388.
10Robashi Y, Matsushima T. Clinieal analysis of patients requiring long-term mechanical ventilation of over three months: Ventilator-associated pneumonia as a primary [J]. lntern-Med, 2003, 42(l):25-32.
